Literature DB >> 12685868

Expression analysis of recombinant lysyl oxidase (LOX) in myofibroblastlike cells.

Sophie Seve1, Marie Decitre, Claudine Gleyzal, Jean Farjanel, Alain Sergeant, Sylvie Ricard-Blum, Pascal Sommer.   

Abstract

Lysyl oxidase (LOX), originally known as the enzyme required for initiation of covalent cross-linking in collagens and elastin, is now known to be a member of a family of genetically related proteins. LOX, or a related protein, has also been localized intracellularly, both in association with the cytoskeleton and in the cell nucleus. To determine the structural requirements for secretion, maturation, and nuclear location of LOX in a cellular context, we have devised an homologous cell model for expression of the recombinant protein. Murine recombinant LOX was expressed in 3T6-5 myofibroblast-like cells as a 51-kD precursor, which was observed in the cytoplasm but not in the nucleus. To investigate whether potential alternative translation initiation sites were involved in specifying a nuclear form of LOX, constructs mutated or deleted for ATG(+1) were used, but alternative initiation at CTG(-315) or ATG(+418) did not lead to the expression of intranuclear forms. Residues 23 to 157 of the proregion were essential for export of the precursor, while mutation of the putative site for maturation by procollagen C-proteinase abolished processing to the mature form of the enzyme. Cross-linking of collagen, as measured by pyridinoline analysis, increased twofold with the recombinant cells, compared to non-transfected controls. This shows the specific contribution of LOX, as opposed to other genetic forms of the enzyme, to cross-linking in a cellular context.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12685868

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  8 in total

1.  A general protease digestion procedure for optimal protein sequence coverage and post-translational modifications analysis of recombinant glycoproteins: application to the characterization of human lysyl oxidase-like 2 glycosylation.

Authors:  Kathryn R Rebecchi; Eden P Go; Li Xu; Carrie L Woodin; Minae Mure; Heather Desaire
Journal:  Anal Chem       Date:  2011-10-27       Impact factor: 6.986

2.  Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.

Authors:  Kazushi Okada; Hee-Jung Moon; Joel Finney; Alex Meier; Minae Mure
Journal:  Biochemistry       Date:  2018-12-13       Impact factor: 3.162

3.  The Ras signaling inhibitor LOX-PP interacts with Hsp70 and c-Raf to reduce Erk activation and transformed phenotype of breast cancer cells.

Authors:  Seiichi Sato; Philip C Trackman; Joni M Mäki; Johanna Myllyharju; Kathrin H Kirsch; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

4.  Characterization of recombinant lysyl oxidase propeptide.

Authors:  Siddharth R Vora; Ying Guo; Danielle N Stephens; Erdjan Salih; Emile D Vu; Kathrin H Kirsch; Gail E Sonenshein; Philip C Trackman
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

5.  A novel proteolytic processing of prolysyl oxidase.

Authors:  Phimon Atsawasuwan; Yoshiyuki Mochida; Michitsuna Katafuchi; Kentaro Tokutomi; Viorel Mocanu; Carol E Parker; Mitsuo Yamauchi
Journal:  Connect Tissue Res       Date:  2011-05-18       Impact factor: 3.417

6.  Role of lysyl oxidase propeptide in secretion and enzyme activity.

Authors:  Jessica L Grimsby; Hector A Lucero; Philip C Trackman; Katya Ravid; Herbert M Kagan
Journal:  J Cell Biochem       Date:  2010-12-01       Impact factor: 4.429

7.  A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.

Authors:  Chengyin Min; Ziyang Yu; Kathrin H Kirsch; Yingshe Zhao; Siddharth R Vora; Philip C Trackman; Douglas B Spicer; Lynn Rosenberg; Julie R Palmer; Gail E Sonenshein
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

8.  The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells.

Authors:  Yingshe Zhao; Chengyin Min; Siddharth R Vora; Philip C Trackman; Gail E Sonenshein; Kathrin H Kirsch
Journal:  J Biol Chem       Date:  2008-11-21       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.